Cargando…

miR-148a-3p suppresses epithelial ovarian cancer progression primarily by targeting c-Met

MicroRNAs (miRNAs) are a group of small non-coding RNAs that modulate post-transcriptional gene expression. It has been demonstrated that various miRNAs may be expressed at different levels in different types of tumors. The present study assessed the role of microRNA-148a-3p (miR-148a-3p) in epithel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wen, Dong, Jing, Wang, Maoxiu, Yao, Shujuan, Tian, Xiangyu, Cui, Xiujuan, Fu, Shijie, Zhang, Shiqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876423/ https://www.ncbi.nlm.nih.gov/pubmed/29616095 http://dx.doi.org/10.3892/ol.2018.8110

Ejemplares similares

Upstream transcription factor 1 prompts malignancies of cervical cancer primarily by transcriptionally activating p65 expression
por: Wang, Wen, et al.
Publicado: (2018)

Monensin suppresses cell proliferation and invasion in ovarian cancer by enhancing MEK1 SUMOylation
por: Yao, Shujuan, et al.
Publicado: (2021)

MicroRNA-217 functions as a tumor suppressor in cervical cancer cells through targeting Rho-associated protein kinase 1
por: Dong, Jing, et al.
Publicado: (2018)

Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells
por: Døssing, Kristina B. V., et al.
Publicado: (2018)

Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation
por: Zhou, Xin, et al.
Publicado: (2022)

miR‐148a suppresses inflammation in lipopolysaccharide‐induced endometritis
por: Jiang, Kangfeng, et al.
Publicado: (2019)

Therapeutic Delivery of miR-148a Suppresses Ventricular Dilation in Heart Failure
por: Raso, Andrea, et al.
Publicado: (2019)

miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2
por: Cao, Huiyan, et al.
Publicado: (2022)

miR-148 Regulates Mitf in Melanoma Cells
por: Haflidadóttir, Benedikta S., et al.
Publicado: (2010)

miR-148a suppresses cell invasion and migration in gastric cancer by targeting DNA methyltransferase 1
por: Shi, Huaijie, et al.
Publicado: (2018)

miR-148 family members are putative biomarkers for sepsis
por: Dong, Lei, et al.
Publicado: (2019)

The suppressive role of miR-362-3p in epithelial ovarian cancer
por: Yuan, Jialing, et al.
Publicado: (2020)

Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
por: Shen, Jie, et al.
Publicado: (2014)

Epidrug Modulated Expression of MiR-152 and MiR-148a Reverse Cisplatin Resistance in Ovarian Cancer Cells: An Experimental In-vitro Study
por: Khajehnoori, Sahel, et al.
Publicado: (2020)

MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer
por: Xu, Xin, et al.
Publicado: (2016)

Targeting miR-148b-5p Inhibits Immunity Microenvironment and Gastric Cancer Progression
por: Zhang, Yuyu, et al.
Publicado: (2021)

Overexpression of miR-148a inhibits viability and invasion of ovarian cancer OVCAR3 cells by targeting FOXO3
por: Zhu, Dandan, et al.
Publicado: (2019)

miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma
por: Wu, Ying, et al.
Publicado: (2016)

MiR-148a inhibits angiogenesis by targeting ERBB3()
por: Yu, Jing, et al.
Publicado: (2011)

MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway
por: Zhang, Jun-gang, et al.
Publicado: (2015)

The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2020)

Oestrogen induces epithelial‐mesenchymal transition in endometriosis via circ_0004712/miR‐148a‐3p sponge function
por: He, Xin, et al.
Publicado: (2020)

c-Met and miRs in Cancer
por: Giglio, Simona, et al.
Publicado: (2015)

miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer
por: Dai, Wenzhu, et al.
Publicado: (2019)

miR-381-3p suppresses breast cancer progression by inhibition of epithelial–mesenchymal transition
por: Yu, Yong-Zheng, et al.
Publicado: (2021)

Dysregulation of the miR-148a–GLUT1 axis promotes the progression and chemoresistance of human intrahepatic cholangiocarcinoma
por: Tiemin, Pei, et al.
Publicado: (2020)

Corrigendum: MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway
por: Zhang, Jun-gang, et al.
Publicado: (2017)

Role of miR-148a in Hepatitis B Associated Hepatocellular Carcinoma
por: Yuan, Ke, et al.
Publicado: (2012)

Identification of miR-148a as a novel regulator of cholesterol metabolism
por: Goedeke, Leigh, et al.
Publicado: (2015)

miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1
por: Wang, Yanan, et al.
Publicado: (2018)

miR-148a Regulates the Stem Cell-Like Side Populations Distribution by Affecting the Expression of ACVR1 in Esophageal Squamous Cell Carcinoma
por: Tan, Yao, et al.
Publicado: (2020)

Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus
por: Hezova, Renata, et al.
Publicado: (2015)

The Role of Mir-148a in Cancer
por: Li, Yue, et al.
Publicado: (2016)

Expression of the miR-148/152 Family in Acute Myeloid Leukemia and its Clinical Significance
por: Wang, Xiao-Xue, et al.
Publicado: (2017)

Prognostic value of expression levels of miR-148a, miR-152 and HLA-G in colon cancer
por: Emirzeoglu, Levent, et al.
Publicado: (2022)

Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma
por: Lin, Wenjun, et al.
Publicado: (2018)

Renal miR-148b is associated with megalin down-regulation in IgA nephropathy
por: Wen, Lu, et al.
Publicado: (2018)

MiR-148a deletion protects from bone loss in physiological and estrogen-deficient mice by targeting NRP1
por: Pan, Bin, et al.
Publicado: (2022)

Inhibition of miR‐148a‐3p resists hepatocellular carcinoma progress of hepatitis C virus infection through suppressing c‐Jun and MAPK pathway
por: Deng, Yibin, et al.
Publicado: (2018)

miR-148a-3p suppresses the progression of acute myeloid leukemia via targeting cyclin-dependent kinase 6 (CDK6)
por: Zhou, Hong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iguo4k10i9lapidgf6onja2jol